| Dose |
55Gy |
52.5Gy |
| Adjuvant hormones |
2 years |
None |
Total |
None |
| Survival @ 5yrs (%) |
|
|
|
|
| Overall |
86.3 |
90.6 |
89.5 |
78.3 |
| Cause specific survival rate (CSSR) |
93.4 |
97.8 |
96.7 |
84.7 |
| By prognostic group |
|
|
|
|
| Good |
N/A |
100 |
100 |
97.1 |
| Intermediate |
90.5 |
97.8 |
97.0 |
92.9 |
| Poor |
93.9 |
96.9 |
95.6 |
76.7 |
| Survival @ 10yrs (%) |
|
|
|
|
| Overall |
69.2 |
72.4 |
71.5 |
55.4 |
| Cause specific survival rate (CSSR) |
82.3 |
92.9 |
90.2 |
67.3 |
| By prognostic group |
|
|
|
|
| Good |
N/A |
100.0 |
100.0 |
84.0 |
| Intermediate |
85.7 |
95.3 |
94.3 |
83.2 |
| Poor |
81.6 |
86.7 |
84.3 |
46.8 |
|
